EFCG’s strategy and work are managed by three Committees and one task force who report to and are directed by the EFCG Board


Dr. Steffen Denzinger
Director Business Development Actives & Formulation –
Merck Life Science KGaA

Dr. Gildas Barreyre
Energy and Public Affairs Director –

Ms. Ana Marti
General Counsel, IP & RA – Medichem S.A

Mr. Enrico Allievi
Director – Aschimfarma Federchimica

Mr. Marco Gil
Senior Vice-President sales and marketing – Hovione

Dr. Christine Chartroux
Head of Sales & New Business development – WeylChem
Chair of the FAME Committee

Mr. David Demailly
API Commercial Director – Aspen Oss B.V.

Ms. Mila Jové
General Manager – Afaquim

Dr. Martin Jochen Klatt
Vice-President – BASF SE

Ms. Céline Crusson-Rubio
Managing Director – SICOS

Mrs. Sinead Keogh
Director – BioPharmaChem Ireland

Dr. Gian Paolo Negrisoli
President and CEO – Flamma Group

Dr. Roberta Pizzocaro
President Olon Group

Dr. Jürgen Roos
Chief Scientific Officer – Siegfried Holding AG

Dr. Vincent Touraille
Head of Strategy – EuroAPI – Sanofi Chimie


Mrs. Maggie Saykali
Director, Specialty Chemicals – Cefic